The ministry said Wegovy contains the active ingredient Semaglutide and is authorised for use in the United States since December 2025
This direct contact may enhance local tissue effects beyond what systemic administration achieves
The pacing, the stages, and the decision to move forward all depend on an individualized clinical assessment that accounts for tolerance, health history, and ongoing feedback
Together, these actions help regulate blood sugar levels while facilitating weight loss, making tirzepatide particularly beneficial for individuals with obesity or type 2 diabetes
2021) Adults with obesity, with and without type 2 diabetes (T2D), who took 2.4 mg of semaglutide weekly over 68 weeks experienced a significantly higher change in mean body weight compared to those who took a placebo
Food and Drug Administration approved it in 2014 to help adults with obesity or adults who are overweight and who also have a weight-related health condition lose weight